Research & Development

  • Methadone at home
    Image attribution tooltip
    Stock via Getty Images

    Methadone at home? Emerging tech provides new tool in the fight against opioid addiction

    Sonara Health’s inexpensive, specially engineered label and web app allow for at-home, digitally supervised dosing of high-cost or high-risks drugs.

    By Alexandra Pecci • Sept. 15, 2022
  • Katharine Knobil
    Image attribution tooltip
    Diego Camargo/PharmaVoice

    Woman of the Week: Agilent Technologies’ Dr. Katharine Knobil

    As the first chief medical officer of the diagnostic testing company, Dr. Katharine Knobil is focused on moving the science forward beyond precision oncology to liquid biopsy.

    By Sept. 14, 2022
  • Colonies of bacteria in MacConkey agar
    Image attribution tooltip
    Md Saiful Islam Khan via Getty Images

    Feds could soon bring COVID-style fight to superbug threat

    COVID-19 has inspired renewed urgency in the need for weapons to combat antimicrobial resistant infections and new hope of government funding to meet the challenge.

    By Sept. 13, 2022
  • Male patient using tablet computer with female doctor in clinic
    Image attribution tooltip

    Cavan Images/

    Sponsored by CorEvitas

    Clinical registry data, a valuable source of real-world data

    Real-world data (RWD) from clinical drug registries can and should be used throughout the drug development lifecycle. At all stages, registries ensure that assumptions about the current standard of care are accurate and evidence-based.

    By CorEvitas • Sept. 6, 2022
  • A 3D illustration of sickled cells in blood
    Image attribution tooltip
    Artur Plawgo via Getty Images

    Pharma’s renewed sickle cell investment lifts a once-shirked disease

    Pfizer's $5.4 billion deal to acquire Global Blood Therapeutics invigorated the fast-growing market, and patients are fit to be the benefactors.

    By Kelly Bilodeau • Sept. 1, 2022
  • Kim Boericke headshot
    Image attribution tooltip
    Diego Camargo/PharmaVoice

    Woman of the Week: Thread’s Kim Boericke

    Fresh off an eight-year tour of duty at ICON, the CRO industry veteran is stepping into a new role and a new title as chief delivery officer at Thread.

    By Aug. 31, 2022
  • Glass vials of Moderna COVID-19 vaccine.
    Image attribution tooltip
    Gabriel Kuchta via Getty Images

    Moderna’s lawsuit against Pfizer and BioNTech explained in 10 quotes

    The biotech says that its competitors’ COVID-19 vaccine copied proprietary mRNA technology. Here’s a breakdown of the case.

    By Aug. 31, 2022
  • A view from below of the CVS sign on the center of a building, with a vertical blue HealthHub sign to its right.
    Image attribution tooltip
    Mario Tama via Getty Images

    Parexel joins pharmacy giants in quest to boost community health clinical trials

    The Community Alliance Network is the latest industry initiative looking to the pharmacy counter to help improve trial recruitment diversity.

    By Taren Grom and Karissa Waddick • Aug. 30, 2022
  • inside cell
    Image attribution tooltip
    Stock via Getty Images

    Leading the industry’s next potential game-changer in drug discovery

    Rachel Meyers, chief scientific officer at Faze Medicines, is helping guide the company towards the development of biomolecular condensates — an emerging field that could transform drug discovery.

    By Alexandra Pecci • Aug. 29, 2022
  • Long COVID
    Image attribution tooltip
    Jikaboom via Getty Images

    The ‘long COVID’ nightmare: Data-driven alliance offers understanding of the lasting viral impact

    A collaboration between Stanford University researchers and Komodo Health aims to advance knowledge of lingering COVID symptoms, health disparities and intervention strategies.

    By Aug. 29, 2022
  • Piggy bank medical
    Image attribution tooltip
    Snezhana Kudryavtseva via Getty Images

    With market success at stake, can tech help solve the diversity problem in clinical trials?

    Diversity in clinical trials isn’t only important for the health of the overall patient population — it can save millions in lost profits.

    By Kelly Bilodeau • Aug. 24, 2022
  • Tram Tran Glympse Bio
    Image attribution tooltip
    Diego Camargo/PharmaVoice

    Woman of the Week: Glympse Bio’s Dr. Tram Tran

    How the chief medical officer of the emerging diagnostic company is using the patient perspective as a guiding light.

    By Aug. 24, 2022
  • Brain puzzle
    Image attribution tooltip
    designer491 via Getty Images

    Overcoming mental health’s drug development challenges with AI

    PsychoGenics is leveraging AI-driven drug discovery platforms to advance mental health treatments for schizophrenia, bipolar disorder and treatment-resistant depression.

    By Kelly Bilodeau • Aug. 23, 2022
  • Brian Goff stands laughing in the forefront, with a crowded room of business attire-clad people in the background.
    Image attribution tooltip

    Permission granted by Brian Goff. 


    First 90 Days: Agios Pharmaceuticals’ Brian Goff

    The rare disease veteran and first-time CEO is bringing his expertise to the company as it launches the first FDA-approved treatment for pyruvate kinase (PK) deficiency.

    By Alexandra Pecci • Aug. 22, 2022
  • Teresa Bitetti Takeda Oncology
    Image attribution tooltip
    Diego Camargo/PharmaVoice

    Woman of the Week: Takeda Oncology’s Teresa Bitetti

    Upon joining Takeda Pharmaceuticals as president of the global oncology unit, Teresa Bitetti had two important goals: to transform the business and create greater synergies between commercial and R&D operations.

    By Aug. 17, 2022
  • Pill
    Image attribution tooltip
    Liudmila Chernetska via Getty Images

    Inventing the COVID vax pill: a matter of convenience and durability

    Recent data from Vaxart’s phase 1 trial of its COVID-19 inoculation pill shows potential.

    By Kelly Bilodeau • Aug. 17, 2022
  • George Magrath wears blue scrubs and sits over a patient.
    Image attribution tooltip

    Permission granted by George Magrath. 

    The CEO in the ophthalmologist’s coat

    In balancing two roles — Lexitas CEO and practicing physician — George Magrath brings a patient-first perspective to developing and advancing eye treatments.

    By Alexandra Pecci • Aug. 16, 2022
  • Nasal spray
    Image attribution tooltip
    Evgenyi_Eg via Getty Images

    Right under our noses: Could COVID-19 vaccines be better as nasal spray?

    Nasal vaccines under development by Codagenix, Xanadu Bio and others have the potential to finally help reduce virus transmission and breakthrough infections.

    By Kelly Bilodeau • Aug. 16, 2022
  • Seen from behind, a clinician is using a cell phone and checking a patient's electronic health record on a laptop.
    Image attribution tooltip
    iStock via Getty Images

    How real world evidence is impacting rare disease drug development

    ICON’s Will Maier shares how a more patient-focused approach to trials is leading to alternatives for randomization.

    By Kim Ribbink • Aug. 9, 2022
  • A baby harp seal pup lays on ice in the White Sea.
    Image attribution tooltip
    iStock via Getty Images

    Turning harp seal contraceptives into a ‘new genre’ of cancer treatments

    With Andrew Hall at its helm, IMV has evolved an animal contraceptive into a unique drug delivery platform aimed at creating targeted cancer immunotherapies for humans.

    By Alexandra Pecci • Aug. 9, 2022
  • monkeypox vax
    Image attribution tooltip
    Mario Tama via Getty Images

    The ‘alarming’ spread of Monkeypox — by the numbers

    With vaccine and treatment supplies constrained, the virus is becoming ‘less predictable.’

    By Aug. 8, 2022
  • A hand picks a blue figurine out of rows of similar wooden figurines.
    Image attribution tooltip
    Ivan Balvan via Getty Images

    Editas, Real Chemistry and Compass blaze new trails with pivotal C-suite hires

    How these latest executive personnel changes are impacting the industry. 

    By Aug. 3, 2022
  • A collage of pnk, blue and orange bacteria-like blobs float around against a dark blue background.
    Image attribution tooltip
    iStock via Getty Images

    Taking probiotics where they’ve never gone before

    How Seed Health is transforming the microbiome therapeutic market with its pharma-focused drug development approach.

    By Aug. 2, 2022
  • A physician in a white scrubs assists a blue-shirted patient.
    Image attribution tooltip
    iStock via Getty Images

    ‘Death by 1,000 cuts:’ How emerging tech could change the journey for ALS patients

    EverythingALS aims to speed drug development through improved diagnostics.

    By Kelly Bilodeau • Aug. 2, 2022
  • Artifical intelligence
    Image attribution tooltip
    Olemedia via Getty Images

    How a speech analysis tool could transform diagnosis and research for Alzheimer’s and beyond

    WinterLight’s machine learning platform assesses speech to more accurately identify neurodegenerative diseases.

    By Kim Ribbink • Aug. 1, 2022